Page 136 - MEMORIA ANUAL 2020

MEMORIA ANUAL 2020
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
M, Germing U, Zhang Y, Gundem G, Sarian A, van de Loosdrecht AA, Jädersten M, Tobiasson M, Kosmider O, Follo MY, Thol F, Pinheiro RF, Santini V, Kotsianidis I, Boultwood J, Santos FPS, Schanz J, Kasahara S, Ishikawa T, Tsurumi H, Takaori-Kondo A, Kiguchi T, Polprasert C, Bennett JM, Kli- mek VM, Savona MR, Belickova M, Ganster C, Palomo L, Sanz G, Ades L, Della Porta MG, Elias HK, Smith AG, Werner Y, Patel M, Viale A, Vanness K, Neuberg DS, Stevenson KE, Menghrajani K, Bolton KL, Fenaux P, Pellagatti A, Platzbecker U, Heuser M, Valent P, Chiba S, Miyazaki Y, Finelli C, Voso MT, Shih LY, Fontenay M, Jansen JH, Cervera J, Atsuta Y, Gattermann N, Ebert BL, Béjar R, Greenberg PL, Cazzola M, Hellström-Lindberg E, Ogawa S, Papaemmanuil E.
• The implication of ‘unknown significance’ variants in next-generation sequencing in diagnosis and donor selection for allogenic haematopoietic stem cell transplantation. Report of a case of myelodysplastic syndrome with a polymorphism in the tyrosine kinase 2 (TYK2) gene.
Br J Haematol. 2020 May;189(4):e182-e184. doi: 10.1111/bjh.16590. PMID: 32266710.
López-Andrade B, Bento L, Díez Campelo M, López Cadenas F, González Martín T, Lo Riso L, Novo A, Martínez-Serra J, Ballester C, Sampol A, Durán MA.
• Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.
Haematologica. 2020 Jul 16;haematol.2020.248807. doi: 10.3324/haematol.2020.248807. Online ahead of print.
Martín-Izquierdo M, Abáigar M, Hernández-Sánchez JM, Tamborero D, López-Cadenas F, Ramos F, Lumbreras E, Madinaveitia-Ochoa A, Megido M, Labrador J, Sánchez-Real J, Olivier C, Dávila J, Aguilar C, Rodríguez JN, Martín-Núñez G, Santos-Mínguez S, Miguel-García C, Benito R, Díez- Campelo M, Hernández-Rivas JM.
• Distinct mutational pattern of Myelodysplastic syndromes with and without 5q- treated with lenalidomide.
Br J Haematol. 2020 May;189(4):e133-e137. doi: 10.1111/bjh.16558. PMID: 32147816.
Adema V, Palomo L, Toma A, Kosmider O, Fuster-Tormo F, Benito R, Salgado R, Such E, Larrayoz MJ, Xicoy B, Hernández-Sánchez JM, Maietta P, Neef A, Fontenay M, Ibáñez M, Díez Campelo M, Álvarez A, Maciejewski JP, Fenaux P, Solé F.
GRUPO ESPAÑOL DE SÍNDROMES MIELODISPLÁSICOS (GESMD)
136